The future of monitoring drug activity markers during therapy
By: Abingdon Health
This of course requires a flexible testing method.
So, are there drug therapy monitoring methods that can address patient anxiety and help reduce hospital or medical centre visits while also offering a more appealing solution to tight healthcare budgets and reduce front-line staff workload?
Companion and complementary lateral flow near-patient tests are being utilised extensively across regulated industries for the rapid production of qualitative, semi- and fully-quantitative results.
The technology is favoured for its ease of use, cost-effectiveness and the ability to be configured to detect a multitude of markers in various samples, and in a variety of near-patient, home, over the counter and clinical testing scenarios.
Also, utilising lateral flow with a smartphone or desktop reader data solution is revolutionising how healthcare providers assess, diagnose and monitor disease status: these data solutions are creating value for all stakeholders via the production of real-time data.
Lean more about the future of monitoring drug activity markers during therapy at https://www.abingdonhealth.com/